Time to Talk CINV TM
After survey results showed that 95% of patients who have experienced chemotherapy-induced nausea and vomiting (also known as CINV) said at some point the side effect had an impact on their daily lives, we knew something more had to be done to help patients. HOPA teamed up with Eisai Inc. and Helsinn Therapeutics (U.S.), Inc. to launch the Time to Talk CINV™ program to help address unmet needs regarding the communication of nausea and vomiting from chemotherapy and ensure that no patient suffers needlessly.
As part of the campaign, the Time to Talk CINV toolkit was created. This action-oriented toolkit is available to patients, their caregivers and their healthcare team to help communicate about the prevention of nausea and vomiting from chemotherapy. Whether a patient is just starting chemotherapy or has been on chemotherapy before and experienced nausea and vomiting, these materials were tailor-made with the guidance of patients, nurses and pharmacists to encourage open communication between the patient, caregiver and healthcare team about nausea and vomiting.
These tools can be printed, filled out digitally, emailed and shared via social media.
Video Guide to Using the Toolkit
Time to Talk CINV Toolkit
For Patient Use:
Patient Checklist: Here's a list of things to ask your healthcare team when starting your chemotherapy regimen. Remember to bring paper or the notes page (link below) to jot down information.
Myths and Facts about CINV: With so many misperceptions about chemotherapy-induced nausea and vomiting, use this tool to learn the facts about this side effect.
CINV Notes Page: Print out this notes page to keep track of your side effects, instructions from your doctor or questions about your treatment. Use it at home or during visits with your healthcare team.
Toolkit Infographic: Discover how our new toolkit works and what you can do to help prevent CINV.
For the Healthcare Team Use:
Healthcare Team Best Practices Checklist: Ensure you and your team are doing everything you can to communicate about the prevention of CINV.
Guide to use the Tools: Learn more about how patients and healthcare providers can utilize the Time to Talk CINV toolkit by reviewing this guide, which can be printed for repeated use.
More about CINV and Time to Talk CINV Campaign:
A Patient’s Journey: Former HOPA president, Scott Soefje, discusses the impact CINV has on patients and the importance of communication between patients and their healthcare team.
CINV Infographic: Gain a better understanding of CINV, how to prevent it and why it matters.
Survey Infographic: View the surprising results from our 2015 national survey about the impact CINV has on the lives patients receiving chemotherapy.
2017 Press Release: “Available Now: New Toolkit Encourages Better Communication to Help Prevent Patients from Suffering in Silence Due to Chemotherapy-induced Nausea and Vomiting”
Read about the launch of the Time to Talk CINV toolkit, highlighting the patient and healthcare provider resources developed by HOPA, Eisai and Helsinn.
2015 Press Release: “Results of Hematology/Oncology Pharmacy Association and Eisai Inc. Survey Show 83 Percent of Patients Receiving Chemotherapy May Be Unnecessarily Suffering from Chemotherapy-induced Nausea and Vomiting”
Learn more about the launch of the Time to Talk CINV campaign.
Time to Talk CINV™ is a collaboration between the Hematology/Oncology Pharmacy Association, Eisai Inc., and Helsinn Therapeutics (U.S.), Inc. The Time to Talk CINV campaign is funded by Eisai Inc. and Helsinn Therapeutics (U.S.), Inc.